Johnson & Johnson Texas Two-Step 2021-2025 : J&J Created a Company Just to Go Bankrupt | File 158 T1

This episode is part of Financial Forensics Labs — two shows, one forensic methodology: The Due Diligence Files traces how institutions collapse, The Signal Files traces how the good calls get made. Built from primary-record research by a 15-year capital markets professional. Get to know the framework, the other show, and the tools built from it — all in one place. Explore ⁠⁠Financial Forensics Labs — Forensic Finance Intelligence⁠ A federal appeals court once wrote that there was an "apparent irony" in its own ruling: the very financial strength Johnson & Johnson used to reassure the public was the exact reason a federal court said its subsidiary didn't qualify for bankruptcy protection at all.

In 2021, J&J split its consumer products business in two. One company kept the brands, the factories, the revenue -- Band-Aid, Tylenol, Aveeno, Listerine. The other, LTL Management, got almost nothing except nearly all of the talc-related lawsuits and a $61.5 billion funding backstop from its former parent. Two days later, LTL filed for Chapter 11, instantly freezing more than 38,000 pending lawsuits nationwide -- many involving mesothelioma and ovarian cancer patients with limited time.

This episode is the financial autopsy of the "Texas Two-Step" -- the restructuring maneuver J&J tried three separate times, in two different states, over roughly four years, and lost three times, always on some version of the same finding: the company was never in the kind of financial distress bankruptcy protection exists to address, because its own funding agreement guaranteed it wasn't.

What you'll learn:

- How a Texas divisional merger legally splits a company's assets from its liabilities in a single transaction - Why the Third Circuit dismissed J&J's first bankruptcy filing in January 2023 -- and the "apparent irony" the judges flagged themselves - What happened when LTL refiled hours after its first dismissal, and why that failed too - How a third attempt, through a new entity called Red River Talc, collected an 83% claimant approval vote and still got rejected by a Texas court in 2025 - Where the underlying talc litigation stands today, including a $1.5 billion jury verdict in December 2025 - Why Chapter 11's good-faith requirement did exactly what it was designed to do, three times, against one of the best-resourced legal teams in the world

This is not a story about concealment or accounting fraud. Everything here was disclosed and litigated openly in public court opinions -- which is what makes it worth studying: a fully transparent legal strategy, built by sophisticated counsel, defeated repeatedly by one consistent standard.

Financial Forensics Labs breaks down real corporate collapses, fraud cases, and legal engineering failures -- the mechanism, the red flags visible before the outcome, and what any investor, creditor, or deal team should check before capital is on the line. Built from public filings, court opinions, and verified reporting -- no speculation.

Want the full Forensic Data Sheet for this case, source documents included, plus early access to our offline due diligence toolkit? Join our private Substack community -- link in the episode notes.

Keywords: Johnson and Johnson bankruptcy, Texas Two-Step, LTL Management, talc lawsuit, mass tort bankruptcy, divisional merger, Chapter 11 good faith, corporate restructuring, asbestos litigation, baby powder lawsuit, financial forensics Every collapse has a pattern. We dissect it. Layer by layer. Financial Forensics Labs: The Due Diligence Files.